Call for papers

Journal of Nuclear Energy Science & Power Generation Technology is pleased to announce Special issue on “Nuclear Industry’s response to COVID-19 outbreak”.

Amidst the global COVID-19 pandemic, nuclear medicine is having its time to shine. Nuclear medicine, which relies on the use of radioactive drugs or radiopharmaceuticals (RPs) for either diagnostic or therapeutic purpose, has rapidly become a crucial medical field. Nuclear-derived techniques, such as RT-PCR, are important tools in the rapid detection and characterization of viruses, like the one causing COVID-19.

Nuclear Medicine has played a key role in diagnosing and treating a variety of diseases, including cancer, heart, lung and kidney conditions as well as infectious diseases by injecting a radiolabeled molecule as a biomarker and thus nuclear-assisted tests can be used to detect the novel coronavirus and track its transmission paths.

With the same purpose our Journal “Journal of Nuclear Energy Science & Power Generation Technology” is announcing Special issue Call for paper on “Nuclear Industry’s response to COVID-19 outbreak”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.

Submission Process

Special issue articles can include both original unpublished research articles and review articles related to the specific theme
Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
All the articles in special issues should strictly adhere to journal style and formatting.
Each special issue can be created with 5-7 articles.
All accepted manuscripts can be submitted online via https://www.scholarscentral.org/submissions/nuclear-energy-science-power-generation-technology.html or through an email id to [email protected] .
Submission should be accompanied by a cover letter with reference to the concerned special issue theme.